Protean provides full support for cancer patients from diagnosis to treatment, as well as access to clinical trials and specialty tests.
Risk Analysis & Cancer Detection
We have specific screening tests for the early detection and diagnosis of cancer.
Early cancer detection tests
Cancer recurrence monitoring tests
Risk MAPS™ is a genetic test that can be used to identify hereditary cancer risk.
Performed with a saliva sample
Results within 2-3 weeks
We have specific screening tests for the early detection and diagnosis of cancer.
Early cancer detection tests
Cancer recurrence monitoring tests
We have specific screening tests for the early detection and diagnosis of cancer.
Early cancer detection tests
Cancer recurrence monitoring tests
Rapid Testing for Lung Cancer
Protean’s rapid lung cancer testing matches patients with treatment opportunities recommended by NCCN guidelines, with results in 2-3 days.
Molecular testing can detect genetic mutations, enabling eligibility for targeted therapies. Patients with actionable alterations that are treated with targeted therapy have 50% higher survival rates than those who receive chemotherapy or immunotherapy.
Consultations with Cancer Experts
Protean’s experts will work with your current care team, to provide you with new insights and access to exclusive tests and treatments.
Consultations include the gathering of medical records and specimens, pathology review with recommended next steps, and the coordination of recommended testing.
OnkoSkan™
OnkoSkan™ is a revolutionary test that can be used for screening and treatment monitoring of many types of cancer.
Through a simple blood test, OnkoSkan™ detects the presence of hPG80, a biomarker associated with cancer activity in people 18 years and older.
ClarityDx for Prostate
Clarity Dx for Prostate is a decision support tool that helps patients with elevated PSA make informed decisions about need for prostate biopsy.
This test provides a risk score based on clinical and biological biomarkers. Clinical data shows that the utilization of Clarity Dx could reduce unnecessary prostate biopsies by up to 47%.
Virtual Tumor Boards
Protean’s virtual tumor boards allow you and your doctor to have your case reviewed by experts around the world.
